Abstract:OBJECTIVETo investigate the expression level of Shp-2 tyrosine phosphatase in chronic myeloid leukemia (CML) and its relationship with the unlimited growth and apoptosis resistance of p210 bcr/abl-induced malignant cells.METHODSIn this study, p210 bcr/abl positive leukemia cell specimens were obtained from 25 CML cases, meanwhile, bone marrow and peripheral blood cell samples from 8 non-tumor individuals and 10 normal individuals were used as p210 bcr/abl negative controls. K562 and KU812 leukemia cells were used as p210 bcr/abl positive controls, and KG-1 leukemia cell line was used as Shp-2 positive control. Specimens of peripheral blood and bone marrow of 25 adult patients of chronic myelocytic leukemia, 15 males and 10 females, aged 28-64, were collected. Specimens of bone marrow of 8 basically healthy adult volunteers and specimens of peripheral blood of 10 healthy adult volunteers were used as controls. The total cell protein was collected and the expression of Shp-2 was examined by Western blotting. Human leukemia cells of the line K562 were cultured. Shp-2 specific sense and antisense oligonucleotides were added into the culture fluid respectively. The cell apoptosis was detected by flow cytometry (FCM). STI571, specific inhibitor of p210 bcr/abl was added into the cultured fluid of K562 cells, then Western blotting and FCM were used to detect the protein expression of Shp-2 and p210 bcr/abl, and cell apoptosis.RESULTSPhosphorylated Shp-2 (pShp)-2 protein was overexpressed in 92% (23/25) of the CML cells, but lowly expressed or not expressed in the normal hematopoietic cells. The mean pShp-2 protein/beta-actin ratio of the primary CML leukemia cells was 0.91 +/- 0.62, significantly higher than those of the normal bone marrow cells and peripheral blood hematopoietic cells (0.16 +/- 0.09 and 0.03 +/- 0.05 respectively, both P < 0.01). The apoptotic rates of the CML cells treated by Shp-2 specific antisense oligonucleotide of the concentrations of 1 micromol/L and 4 micromol/L respectively for 72 h was 7.98% and 20.29% respectively, both significantly higher than that of the control group (4.06%, P < 0.01). The number of clone of CML cells treated by 0.25 micromol/L and 1.0 micromol/L Shp-2 specific antisense oligonucleotide for 7 days were 67% (37/60) and 11.9% (5/42) that of the control group. Twenty-four and 48 hours after the stimulation of STI571 the expression level of Shp-2 protein in the CML cells decreased time-dependently and the CML cell apoptotic rates were 31.15% and 38.69% respectively, both lower than that of the control group (33.6%). The number of clone of CML cells effected by 0.25 micromol/L and 1.0 micromol/L Shp-2 specific antisense oligonucleotide for 7 days was 67% (37/60) and 11.9% (5/42) that of the control group. Twenty-four and 48 hours after the stimulation of STI571 the expression level of Shp-2 protein in the CML cells decreased time-dependently and the CML cell apoptotic rates were 31.15% and 38.69% respectively, both lower than that of the control group (33.6%).CONCLUSION(1) The pShp-2 protein is overexpressed in CML cells, which is associated with the unlimited growth and apoptosis resistance of malignant cells. (2) Shp-2 is upregulated by p210 bcr/abl oncoprotein in CML.

Cell Cycle-Dependent Expression of P42.3 Promotes Mitotic Progression in Malignant Transformed Cells.

Overexpression of P42.3 Promotes Cell Growth and Tumorigenicity in Hepatocellular Carcinoma

p42.3: A promising biomarker for the progression and prognosis of human colorectal cancer

Depletion of P42.3 Gene Inhibits Proliferation and Invasion in Melanoma Cells

Identification and Characterization of a Novel P42.3 Gene As Tumor-Specific and Mitosis Phase-Dependent Expression in Gastric Cancer

Differential Expression of P42.3 in Low- and High-Grade Gliomas

PIM3 Functions As Oncogenic Factor and Promotes the Tumor Growth and Metastasis in Colorectal Cancer

Effects of p14ARF-MDM2-p53 Cell Cycle Regulation Pathway on the Carcinogenesis of Cervical Squamous Cell Carcinoma

The potent oncogene NPM-ALK mediates malignant transformation of normal human CD4(+) T lymphocytes

[Overexpression of Shp-2 is Associated with the Unlimited Growth and Apoptosis Resistance of P210 Bcr-Abl-mediated Chronic Myeloid Leukemia].

P53 and P21(waf1) Are Recruited to Distinct PML-Containing Nuclear Foci in Irradiated and Nutlin-3a-Treated U2OS Cells

The Over-Expression of P53 H179Y Residue Mutation Causes the Increase of Cyclin A1 and Cdk4 Expression in HELF Cells

Immune recognition of cyclin B1 as a tumor antigen is a result of its overexpression in human tumors that is caused by non-functional p53.

Deubiquitinase DUB3 Regulates Cell Cycle Progression via Stabilizing Cyclin A for Proliferation of Non-Small Cell Lung Cancer Cells

P42.3 Gene Expression in Gastric Cancer Cell and Its Protein Regulatory Network Analysis

Expression of Pin1 in Malignant Hematopoietic Cells and Its Relation with Cell Cycle

p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage.

A double dealing tale of p63: an oncogene or a tumor suppressor

MicroRNA-423 Promotes Cell Growth and Regulates G 1 /S Transition by Targeting P21cip1/waf1 in Hepatocellular Carcinoma

Cyclin-Dependent Kinase Inhibitor 3 is Overexpressed in Hepatocellular Carcinoma and Promotes Tumor Cell Proliferation

Alterations Of The P53 Tumor-Suppressor Gene In Transformed Mouse-Liver Cells